| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.075 | 0.03 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.082 | 0.04 |
| mRNA | selumetinib:decitabine (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.065 | 0.04 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |